Resources

Medication Abortion Related Litigation

• Mifepristone Related Litigation As of January 5, 2026 - EMAA Project

Public opinion supports medication abortion care.

• Navigator Research - September 2024
• IPSOS Poll - March 2024
• GQR and RedBud Consulting Poll - March 2024
• Lake Research Memo - 2023
• Gallup - June 2023
• Washington Post poll - May 2023
• NPR poll - April 2023
• Pew Research Poll - April 2023
• Ipsos - Feb 2023

Medication abortion care is safe, effective, and FDA approved.

• FAQ REMS Modification January 2023 - EMAA (Expanding Medication Abortion Access)
• Fact Sheet: The Safety of Medication Abortion Care - Expanding Medication Abortion Access (EMAA)
• Fact Sheet: Medication Abortion - Kaiser Family Foundation
• Fact Sheet: Safety and Effectiveness of First-Trimester Medication Abortion in the United States - Advancing New Standards in Reproductive Health
• Timeline of Medication Abortion Care in the United States - Expanding Medication Abortion Access (EMAA)
• The FDA’s Decision Lifting the Burdensome Restriction on Mifepristone during the Pandemic: What You Need to Know - The American College of Obstetricians and Gynecologists

Medication abortion care is different from Emergency Contraception.

• Medication Abortion vs. Emergency Contraception: What’s the Difference? - Expanding Medication Abortion Access (EMAA)
• El Aborto con Medicamentos Versus La Anticoncepción de Emergencia: ¿Cuál Es La Diferencia? - Expanding Medication Abortion Access (EMAA)

Medication abortion care in the news.

Expanding access to mifepristone for miscarriage care.

• Mifepristone and Misoprostol for Miscarriage Management Care - Expanding Medication Abortion Access (EMAA)
• Label change for mifepristone could reduce barriers to care for miscarriages, advocates say in petition to FDA - The 19th
• FDA Citizen Petition to Expand Access to Mifepristone for Miscarriage Care